83.48

0.07% -0.0548

Crinetics Pharmaceuticals Inc (CRNX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CRNX Giù? Forum Previsione

Precedente Chiudi:

$83.53

Aprire:

$83.52

Volume 24 ore:

3.17M

Relative Volume:

1.28

Capitalizzazione di mercato:

$8.84B

Reddito:

$18.07M

Utile/perdita netta:

$-496.39M

Rapporto P/E:

-16.26

EPS:

-5.1333

Flusso di cassa netto:

$-419.52M

1 W Prestazione:

+115.81%

1M Prestazione:

+149.33%

6M Prestazione:

+56.79%

1 anno Prestazione:

+184.22%

Intervallo 1D:

$83.47

$83.57

Intervallo di 1 settimana:

$39.83

$83.63

Portata 52W:

$25.83

$83.63

Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile

Nome

Crinetics Pharmaceuticals Inc

Settore

Healthcare (1097)

Industria

Biotechnology (615)

Telefono

858-450-6464

Indirizzo

6055 LUSK BLVD., SAN DIEGO, CA

Dipendente

594

Cinguettio

@Crinetics

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

CRNX's Discussions on Twitter

Compare CRNX vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRNX Crinetics Pharmaceuticals Inc	83.48	8.84B	18.07M	-496.39M	-419.52M	-5.1333
VRTX Vertex Pharmaceuticals Inc	519.27	132.55B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	666.76	70.90B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	917.72	57.21B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	316.77	42.94B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	192.79	40.49B	742.00K	-1.37B	-1.07B	-7.0731

Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-12	Aggiornamento	Goldman	Neutral → Buy
2025-07-10	Iniziato	Goldman	Neutral
2025-03-25	Iniziato	Stifel	Buy
2025-02-11	Iniziato	TD Cowen	Buy
2025-02-04	Iniziato	Wolfe Research	Peer Perform
2025-01-22	Aggiornamento	Jefferies	Hold → Buy
2024-03-06	Iniziato	Citigroup	Buy
2024-01-16	Iniziato	Morgan Stanley	Overweight
2023-12-21	Iniziato	Jefferies	Hold
2023-11-20	Ripresa	JP Morgan	Overweight
2023-10-24	Ripresa	Cantor Fitzgerald	Overweight
2023-08-31	Iniziato	Oppenheimer	Outperform
2023-04-24	Iniziato	Piper Sandler	Overweight
2023-03-30	Iniziato	Robert W. Baird	Outperform
2021-11-30	Iniziato	JMP Securities	Mkt Outperform
2021-11-23	Iniziato	Evercore ISI	Outperform
2021-06-18	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-23	Iniziato	ROTH Capital	Buy
2019-02-14	Iniziato	H.C. Wainwright	Buy
2018-08-13	Iniziato	JP Morgan	Neutral
2018-08-13	Iniziato	Leerink Partners	Outperform
2018-08-13	Iniziato	Piper Jaffray	Overweight

Mostra tutto

Crinetics Pharmaceuticals Inc Borsa (CRNX) Ultime notizie

05:55 AM

Vertex to acquire Crinetics in deal worth around $10.0bn - PMLiVE

05:55 AM

05:51 AM

Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil - BioSpace

05:51 AM

05:12 AM

Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal - Yahoo Finance

05:12 AM

03:54 AM

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. - The Globe and Mail

03:54 AM

03:28 AM

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. - The Motley Fool

03:28 AM

02:49 AM

The $10B Integration Problem Vertex Hasn’t Solved Yet - The Clinical Trial Vanguard

02:49 AM

01:05 AM

Narrow-Moat Vertex's Strong CF Cash Flows Support Expansion Into Endocrinology Via Crinetics - Morningstar

01:05 AM

12:00 PM

Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know. - The Motley Fool

12:00 PM

Jul 07, 2026

Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms - The Boston Globe

Jul 07, 2026

Crinetics Pharmaceuticals director sells $120,000 in stock - Investing.com

Jul 07, 2026

Vertex Pharma’s Growth Strategy Leads to Its Biggest-Ever M&A Deal - MedCity News

Jul 07, 2026

Form 4 Crinetics Pharmaceuticals Inc For: 7 July By Investing.com - Investing.com India

Jul 07, 2026

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout - Genetic Engineering and Biotechnology News

Jul 07, 2026

Crinetics Pharmaceuticals director sells $120,000 in stock By Investing.com - Investing.com Canada

Jul 07, 2026

Crinetics (CRNX) director sells 3,000 shares at $40 in planned trade - Stock Titan

Jul 07, 2026

Vertex (VRTX) Is Buying Crinetics For $10 Billion And Entering Endocrinology - Yahoo Finance

Jul 07, 2026

Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit - Yahoo Finance

Jul 07, 2026

The Changing Reality of Pharmaceutical Commercialization | PharmExec - Pharmaceutical Executive

Jul 07, 2026

Vertex to buy Crinetics in an all-cash deal valued at $10 billion - CNBC

Jul 07, 2026

Vertex Pays $10 Billion to Enter Rare Endocrine Disease - TradingView

Jul 07, 2026

Vertex's $10B Crinetics deal marks its clearest step yet toward biopharma's top ranks - Endpoints News

Jul 07, 2026

This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal - Barron's

Jul 07, 2026

Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion - Pharmaceutical Executive

Jul 07, 2026

CRNX Soars On $10B Vertex Buyout As Trading Dynamics Shift - StocksToTrade

Jul 07, 2026

CRNX Downgraded by Jones Trading -- Rating Changed to Hold - GuruFocus

Jul 07, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Jul 07, 2026

Crinetics Pharmaceuticals Cut to Hold From Buy by Jones Trading - Moomoo

Jul 07, 2026

Crinetics Pharmaceuticals (CRNX) Agreed To A $10 Billion All Cash Sale To Vertex - simplywall.st

Jul 07, 2026

CRNX Soars On Vertex’s $10B Buyout And Tight Trading Range - StocksToTrade

Jul 07, 2026

Endocrinology becomes Vertex’s fifth pillar with $10B Crinetics buy - BioWorld News

Jul 07, 2026

SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers - marketscreener.com

Jul 07, 2026

Compass says depression drug has long-lasting benefits - STAT

Jul 07, 2026

Crinetics (CRNX) Soars 98.8% to Reach $83.55 - GuruFocus

Jul 07, 2026

CRNX Downgraded by Oppenheimer -- Rating Changed to Perform - GuruFocus

Jul 07, 2026

Vertex Pharmaceuticals (VRTX) Announces Strategic Merger with Cr - GuruFocus

Jul 07, 2026

Vertex makes largest ever acquisition with $10bn Crinetics deal - BioXconomy

Jul 07, 2026

Crinetics Pharmaceuticals stock hits all-time high at 83.59 USD By Investing.com - Investing.com Nigeria

Jul 07, 2026

Jones Trading downgrades Crinetics stock rating on Vertex acquisition - Investing.com

Jul 07, 2026

Crinetics Pharmaceuticals stock hits all-time high at 83.59 USD - Investing.com

Jul 07, 2026

Vertex Pharmaceuticals to acquire Crinetics in a $10 billion deal, sending the latter's share price nearly doubling - 富途牛牛

Jul 07, 2026

Crinetics shares surge after Vertex agrees to $10B cash buyout - Invezz

Jul 07, 2026

Crinetics Pharmaceuticals Stock (CRNX) Opinions on Vertex Acquisition - Quiver Quantitative

Jul 07, 2026

CRNX Stock Soars On $10B Vertex Takeover Deal - StocksToTrade

Jul 07, 2026

Crinetics Acquisition Creates A ‘Fifth Commercial Pillar’ For Vertex, Says Analyst – Why HC Wainwright Sees A 24% Upside Potential In VRTX Stock - Yahoo Finance

Jul 07, 2026

Vertex Pharmaceuticals buying Crinetics for $10 billion - qz.com

Jul 07, 2026